Joseph, N., Inocencio, T., Heitkamp, S., Delea, T., Humblet, O., Bryan, A., Lloyd, J., Ma, Q., Ailawadhi, S. (2026). Net costs associated with inpatient (IP) administration of step-up dosing (SUD) of bispecific antibodies (bsAbs) among Medicare patients (pts) with relapsed/refractory multiple myeloma (MM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e19504